From: An examination of user costs in relation to smokers using a cessation service based in the UK
N (%) | N quit at 12 weeks (%) | ||
---|---|---|---|
Age (mean = 44.8 yrs) | 12–19 yrs | 509 (5.6%) | 116 (22.8%) |
20–29 yrs | 1189 (13.1%) | 296 (24.9%) | |
30–49 yrs | 3911 (43.0%) | 1262 (32.3%) | |
50–69 yrs | 2955 (32.5%) | 1068 (36.1%) | |
70+ yrs | 538 (5.9%) | 192 (35.7%) | |
Gender | Male | 4249 (46.6%) | 1425 (33.5%) |
Female | 4867 (53.4%) | 1510 (31.0%) | |
Treatment | NRT | 7373 (80.1%) | 2117 (28.7%) |
varenicline | 1708 (18.7%) | 799 (46.8%) | |
bupropion | 35 (0.4%) | 19 (54.3%) | |
FTND (Mean = 4.89) | 0–3 | 1534 (26.2%) | 622 (40.5%) |
4–5 | 1884 (32.2%) | 727 (38.6%) | |
6–7 | 1676 (28.6%) | 641 (38.2%) | |
8–10 | 766 (13.1%) | 236 (30.8%) | |
Deprivation (Mean = 7.22) | 1–3 | 886 (10.8%) | 319 (36.0%) |
4–6 | 1838 (22.4%) | 635 (34.5%) | |
7–8 | 2157 (26.3%) | 698 (32.4%) | |
9–10 | 3321 (40.5%) | 1180 (35.5%) |